PTGX stock news
This page provides real-time market news, earnings updates, and company announcements related to Protagonist Therapeutics, Inc. (PTGX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-11 01:08 EST
FDA Grants Priority Review for Takeda (TAK) and Protagonist's Rusfertide in PV Treatment
Finviz2026-03-08 16:03:55
Today's Bullish Patterns & Technical Sentiment | Published on 03/10: APGE, PTGX, BRZE and More
moomoo-证劵2026-03-10 12:48:55
New drug approval boosts market confidence: The US Food and Drug Administration (FDA) has officially approved the oral psoriasis treatment jointly developed by Protagonist Therapeutics and Johnson & Johnson. Driven by this news, Protagonist's stock price rose by about 4% in pre-market trading.
老虎证券2026-03-18 12:26:43
FDA Greenlights J&J's Icotyde, Leading to 5.2% Decline in AbbVie Stock with Trading Volume Placing 41st
101 finance2026-03-18 22:36:49
J&J Grows Its New Drug Lineup Following FDA Clearance of Icotyde
101 finance2026-03-19 17:28:06
Johnson & Johnson Shares Edge Up 0.13% on 47th-Ranked $1.78B Volume Despite FDA Approval of Icotyde
101 finance2026-03-19 22:32:04
Protagonist Therapeutics (PTGX) Jumps 4.7%: Does the Stock Have More Room to Grow?
101 finance2026-03-20 14:09:39
This $116 Million Purchase Accompanies a 360% Surge in Shares and Appears to Show Strong Confidence in a Major Drug Debut
101 finance2026-03-21 23:39:16
Tilly’s (TLYS) Q1 Forecast Challenge: Will Popular Buzz Surpass Underlying Weakness?
101 finance2026-03-23 06:24:50
CTW Launches Kakegurui ALL IN, Advancing its Pipeline of Additional Game Releases
Finviz2026-03-23 12:06:48
Small-cap ETFs Set to Take Center Stage as Market Rotation Boosts Optimism and Earnings Growth
101 finance2026-03-23 20:07:02
J&J Shares Have Remained Above Their 200- and 50-Day SMAs for 8 Months: Is Now a Good Time to Invest?
101 finance2026-03-24 16:09:50
Johnson & Johnson's FDA-Approved Icotyde Muted Stock Reaction as Shares Rank 33rd in $2.13 Billion Trading Volume
101 finance2026-03-24 22:28:09
AbbVie's 64th-Highest Volume Stock Tangles with Icotyde Threat as Earnings Beat and Dividend Strength Offset Generic Pressures
101 finance2026-03-24 22:42:42
Palantir’s suite of software may be the most vulnerable aspect of the Golden Dome, yet could it also present the greatest investment opportunity?
101 finance2026-03-25 00:13:07
ANNA’s Unexpected Geopolitical Move: Small Gas Provider Emerges as Key Player in a 40% Surge Fueled by Headlines During LNG Supply Crisis
101 finance2026-03-25 02:27:52
NXTT Ignites: A 27% Surge Defies Gravity as 52-Week Lows Shatter in Volatile Chaos
101 finance2026-03-25 17:42:39
GCL Announces the PC Release of 'Island of Hearts' - A First-Person FMV Romantic Adventure Filmed on Location in Phuket, Thailand
Finviz2026-03-26 12:06:58
J&J's Expanding Pipeline Paves the Way for Enhanced Growth Driven by Fresh Medications in 2026
101 finance2026-03-26 14:10:04
SUNation Energy Ignites: 20% Surge Defies Sector Gravity as Volatility Soars
101 finance2026-03-26 16:54:46
Can J&J's New Medications Sustain Its Innovative Medicine Segment After Stelara's Loss of Exclusivity?
101 finance2026-03-27 14:18:52
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Finviz2026-03-28 14:12:37
Protagonist CEO Offloads Shares After 1,080% Surge—Has the Stock Reached Its Peak?
101 finance2026-03-28 14:37:01
NIO Achieves Profit for the First Time—Does This Signal the Beginning of a Lasting Recovery?
101 finance2026-04-02 03:30:41
J&J Grows Its New Drug Lineup Following FDA Clearance of Icotyde
101 finance2026-03-19 17:28:06
Johnson & Johnson Shares Edge Up 0.13% on 47th-Ranked $1.78B Volume Despite FDA Approval of Icotyde
101 finance2026-03-19 22:32:04
Protagonist Therapeutics (PTGX) Jumps 4.7%: Does the Stock Have More Room to Grow?
101 finance2026-03-20 14:09:39
This $116 Million Purchase Accompanies a 360% Surge in Shares and Appears to Show Strong Confidence in a Major Drug Debut
101 finance2026-03-21 23:39:16
Tilly’s (TLYS) Q1 Forecast Challenge: Will Popular Buzz Surpass Underlying Weakness?
101 finance2026-03-23 06:24:50
CTW Launches Kakegurui ALL IN, Advancing its Pipeline of Additional Game Releases
Finviz2026-03-23 12:06:48
Small-cap ETFs Set to Take Center Stage as Market Rotation Boosts Optimism and Earnings Growth
101 finance2026-03-23 20:07:02
J&J Shares Have Remained Above Their 200- and 50-Day SMAs for 8 Months: Is Now a Good Time to Invest?
101 finance2026-03-24 16:09:50
Johnson & Johnson's FDA-Approved Icotyde Muted Stock Reaction as Shares Rank 33rd in $2.13 Billion Trading Volume
101 finance2026-03-24 22:28:09
AbbVie's 64th-Highest Volume Stock Tangles with Icotyde Threat as Earnings Beat and Dividend Strength Offset Generic Pressures
101 finance2026-03-24 22:42:42
Palantir’s suite of software may be the most vulnerable aspect of the Golden Dome, yet could it also present the greatest investment opportunity?
101 finance2026-03-25 00:13:07
ANNA’s Unexpected Geopolitical Move: Small Gas Provider Emerges as Key Player in a 40% Surge Fueled by Headlines During LNG Supply Crisis
101 finance2026-03-25 02:27:52
NXTT Ignites: A 27% Surge Defies Gravity as 52-Week Lows Shatter in Volatile Chaos
101 finance2026-03-25 17:42:39
GCL Announces the PC Release of 'Island of Hearts' - A First-Person FMV Romantic Adventure Filmed on Location in Phuket, Thailand
Finviz2026-03-26 12:06:58
J&J's Expanding Pipeline Paves the Way for Enhanced Growth Driven by Fresh Medications in 2026
101 finance2026-03-26 14:10:04
SUNation Energy Ignites: 20% Surge Defies Sector Gravity as Volatility Soars
101 finance2026-03-26 16:54:46
Can J&J's New Medications Sustain Its Innovative Medicine Segment After Stelara's Loss of Exclusivity?
101 finance2026-03-27 14:18:52
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Finviz2026-03-28 14:12:37
Protagonist CEO Offloads Shares After 1,080% Surge—Has the Stock Reached Its Peak?
101 finance2026-03-28 14:37:01
NIO Achieves Profit for the First Time—Does This Signal the Beginning of a Lasting Recovery?
101 finance2026-04-02 03:30:41
PTGX stock chart
PTGX stock detailsPTGX stock price change
On the last trading day, PTGX stock closed at 104.08 USD, with a price change of 1.95% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more